You are viewing: Mexico Pharmaceutical Packaging Market analysis

The Mexico Pharmaceutical Packaging Market was valued at $4357.7 Million in 2025 and projected to reach to $9428.9 Million by 2030, representing a compound annual growth rate of CAGR 16.7%. Mexico's pharmaceutical packaging market is positioned for sustained double-digit growth through 2030, driven by the country's expanding role as a nearshoring destination for North American pharmaceutical manufacturers.

Mexico Pharmaceutical Packaging Market Trends and Insights

  • This represents a compound annual growth rate of 16.7%, significantly outpacing global trends and reflecting Mexico's strategic position as a pharmaceutical manufacturing and distribution hub in North America.
  • Mexico's market growth is driven by increasing domestic pharmaceutical production, rising healthcare demand, and regulatory compliance requirements that necessitate advanced packaging solutions. The forecast period from 2025 to 2030 will see Mexico's pharmaceutical packaging sector nearly double in value, supported by investments in cold-chain logistics, biologics packaging, and sustainable materials.
  • Mexico's proximity to the United States and its established manufacturing infrastructure position the country as a critical node in North American pharmaceutical supply chains.
  • Regulatory harmonization with international standards and growing adoption of serialization and track-and-trace technologies are accelerating market modernization across Mexico's packaging ecosystem..

Key Market Statistics

  • CAGR (2025-2030) CAGR 16.7%
  • Market Size, 2025 ~USD 4357.7 Million
  • Forecast, 2030 ~USD 9428.9 Million
  • Country Mexico

Mexico Pharmaceutical Packaging Market Overview

Exceptional Growth Trajectory :

Mexico's pharmaceutical packaging market is expanding at 16.7% CAGR, outpacing the global rate of 15.8%, driven by increased domestic pharmaceutical manufacturing and cross-border trade with the United States.

Market Valuation Surge :

The market is valued at $4,357.7 million in 2025 and is projected to more than double to $9,428.9 million by 2030, reflecting Mexico's strengthening position in North American pharmaceutical supply chains.

Strategic Manufacturing Hub :

Mexico's role as a pharmaceutical manufacturing and distribution center in North America is accelerating demand for advanced packaging solutions, including blister packs, vials, and specialty containers.

Regulatory and Trade Drivers :

Nearshoring trends, FDA compliance requirements, and USMCA trade agreements are propelling investment in high-quality pharmaceutical packaging infrastructure across Mexico's manufacturing regions.

Mexico Pharmaceutical Packaging Market Dynamics

  • Increasing domestic pharmaceutical production, coupled with rising healthcare consumption and regulatory compliance demands, will continue to fuel demand for innovative packaging solutions.
  • The market will benefit from investments in advanced technologies such as child-resistant packaging, tamper-evident solutions, and sustainable materials.
  • Additionally, Mexico's geographic proximity to the United States and competitive labor costs make it an attractive hub for pharmaceutical companies seeking to diversify supply chains away from Asia..

Related Ecosystem

Resins And Polymers

Top Technologies
  • Polycarbonate
  • Acrylonitrile Butadiene Styrene (ABS)
  • Epoxy Resin
  • Light Commercial Vehicles (LCVs)
  • Polypropylene (PP)
Top Companies
  • Basf se
  • DOW CHEMICAL COMPANY
  • Solvay sa
  • Saudi arabia basic industries corporation (sabic)
  • DuPont de Nemours, Inc.

    Pharmaceuticals

    Top Technologies
    • Bioreactors
    • Analytical Testing
    • Bioanalytical Testing Services
    • Cell Counters
    • Data Management Services
    Top Companies
    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • SANOFI
    • NOVARTIS
    • Pfizer Inc.

      Packaging

      Top Technologies
      • Ampoules
      • Gravure Process
      • Rigid Packaging
      • Aerosols
      • Aseptic Filling and Sealing Equipment
      Top Companies
      • Amcor plc
      • Essentra plc
      • Berry Global Group, Inc.
      • Mondi plc
      • SEALED AIR CORPORATION

        Key Takeaways

        • Mexico's pharmaceutical packaging market will nearly double from $4,357.7M (2025) to $9,428.9M (2030), driven by 16.7% CAGR growth.
        • Mexico's strategic location and manufacturing capabilities position it as a critical pharmaceutical packaging hub for North American supply chains.
        • Cold-chain, biologics, and sustainable packaging solutions are key growth drivers in Mexico's market expansion through 2030.
        • Regulatory compliance and serialization technologies are accelerating modernization and investment in Mexico's pharmaceutical packaging sector.

        Pharmaceutical Packaging Market Report Scope

        Report Metric Details
        Base Year 2025
        Fastest Growing Segment PREFILLED SYRINGES (Type)
        Forecast Period 2025–2030
        Growth Rate CAGR of 15.8% from 2025 to 2030
        Largest Segment INJECTABLE (Drug Delivery)
        Market Size Base Year (Billions) ~USD 174.86 (2025)
        Revenue Forecast (Billions) ~USD 364.11 (2030)
        Segments Covered Raw Material, Drug Delivery, Type, Packaging Type, Drug Delivery Mode

        Mexico Pharmaceutical Packaging Market Report Segmentation

        5 segment dimensions are covered across the global market.

        By Raw Material

        • Glass
        • Metal
        • Other Raw Materials
        • Paper & Paperboard
        • Plastic
        • Plastics

        By Drug Delivery

        • Injectable
        • Injectables
        • Intravenous
        • Nasal
        • Ocular/Ophthalmic
        • Oral
        • Oral Drugs
        • Other Drug Delivery Modes
        • Pulmonary
        • Topical
        • Transdermal

        By Type

        • Ampoules
        • Blister Packs
        • Caps & Closures
        • Cartridges
        • Jars & Canisters
        • Labels & Accessories
        • Medical Specialty Bags
        • Medication Tubes
        • Other Types
        • Plastic Bottles
        • Pouches & Strip Packs
        • Pouches & Strips
        • Prefilled Inhalers
        • Prefilled Syringes
        • Temperature-Controlled Packaging
        • Vials

        By Packaging Type

        • Primary
        • Secondary

        By Drug Delivery Mode

        • Injectable
        • Intravenous
        • Nasal
        • Ocular/Ophthalmic
        • Oral
        • Other Drug Delivery Modes
        • Pulmonary
        • Topical
        • Transdermal

        Target Audience

        • Pharmaceutical Manufacturers : Mexican and multinational pharma companies need market data to optimize packaging sourcing, evaluate local supplier capabilities, and plan production expansion in Mexico.
        • Packaging Solution Providers : Packaging manufacturers and suppliers require detailed market insights to identify growth segments, develop Mexico-specific product offerings, and establish distribution partnerships.
        • Private Equity & Investors : Investment firms evaluating Mexico's pharmaceutical sector need comprehensive market analysis to assess growth potential, identify acquisition targets, and structure funding strategies.
        • Supply Chain & Logistics Companies : 3PL providers and logistics firms need market intelligence to understand pharmaceutical packaging demand patterns, optimize distribution networks, and expand services in Mexico.
        • Government & Trade Organizations : Mexican economic development agencies and trade bodies require market data to support policy decisions, attract foreign investment, and promote pharmaceutical manufacturing competitiveness.

        Key Companies in the Mexico Pharmaceutical Packaging Market

        CompanyHQOwnershipStrongest segments
        TASNEESaudi ArabiaPublic CompanyPetrochemicals (PE, PP compounds, acrylics, solvents),Metallurgy (titanium sponge, slag, pig iron, lead),Downstream plastics (BOPP films, pipes, pallets, agrifilm, sheets, liners),
        LG CHEM LTD.South KoreaPublic CompanyEthylene- and propylene-based synthetic resins,Styrene-based resins and polycarbonate,Advanced materials and battery-related chemistries,
        BOBST GROUP SASwitzerlandPrivate CompanyFolding carton converting (flatbed die-cutters, folder-gluers, related tooling and services),Corrugated board equipment (flexo printing, rotary die-cutters, folder-gluers, converting lines),Flexible packaging and label equipment (vacuum metallizers, coating/laminating, CI/inline flexo, gravure, digital),
        GERRESHEIMER AGGermanyPublic CompanyPrimary Packaging Glass (vials, cartridges, ampoules, flacons),Plastics & Devices (syringes, bottles, closures, medical disposables),Advanced Technologies & Drug Delivery Devices,
        SCHOTT AGGermanyPublic CompanyPrefillable glass syringes (syriQ portfolio),Pharmaceutical glass vials (adaptiQ, EVERIC family),Cartridges (cartriQ and related),
        APTARGROUP, INC.United StatesPublic CompanyPharma (drug delivery, elastomeric components, active material science, digital health),Beauty (fragrance, facial skincare, color cosmetics dispensing),Closures (food, beverage, personal and home care closures and aerosol valves),
        BDUnited StatesPublic Company
        WESTROCK COMPANYUnited StatesPrivate CompanyConsumer packaging solutions,Corrugated packaging solutions,Merchandising display solutions,

        TASNEE

        TASNEE is a Saudi Arabian public company founded in 1984 with 7,000 employees, operating in the petrochemicals and industrial materials industry.

        LG CHEM LTD.

        LG Chem Ltd. is a South Korean public company founded in 1947 with 14,019 employees, specializing in chemicals, advanced materials, and energy solutions.

        BOBST GROUP SA

        Bobst Group SA is a Swiss private company founded in 1890 with 6,314 employees, manufacturing machinery and equipment for the packaging and printing industries.

        GERRESHEIMER AG

        Gerresheimer AG is a German public company founded in 1864 with 13,528 employees, manufacturing specialty glass and plastic packaging for pharmaceuticals and cosmetics.

        SCHOTT AG

        Schott AG is a German public company founded in 1884 with 4,839 employees, producing specialty glass and glass-ceramics for various industrial applications.

        APTARGROUP, INC.

        AptarGroup, Inc. is a United States public company founded in 1992 with 14,000 employees, manufacturing dispensing systems and packaging solutions for beauty, personal care, and pharmaceutical markets.

        BD

        BD (Becton, Dickinson and Company) is a United States public company founded in 1897 with 72,000 employees, specializing in medical devices, diagnostics, and laboratory equipment.

        WESTROCK COMPANY

        WestRock Company is a United States private company founded in 2018 with 56,100 employees, operating as a major manufacturer of paper and packaging products.

        Reasons to Buy this Report

        • Identify High-Growth Opportunities : Gain detailed insights into Mexico's 16.7% CAGR market expansion to identify investment opportunities in pharmaceutical packaging manufacturing, distribution, and technology solutions before competitors.
        • Understand Nearshoring Dynamics : Analyze how nearshoring trends and USMCA trade agreements are reshaping Mexico's pharmaceutical packaging landscape, enabling strategic market entry and partnership development.
        • Competitive Market Positioning : Access comprehensive data on Mexico's pharmaceutical packaging segment to benchmark against competitors, understand market consolidation trends, and identify acquisition targets.
        • Regulatory and Compliance Insights : Understand FDA compliance requirements, Mexican pharmaceutical regulations, and quality standards driving demand for advanced packaging solutions in the Mexican market.
        • Forecast-Driven Strategic Planning : Leverage 2030 market projections ($9.43B) to develop long-term business strategies, capacity planning, and resource allocation for Mexico's pharmaceutical packaging sector.

        Frequently asked questions

        What is the current size of Mexico's pharmaceutical packaging market?

        Mexico's pharmaceutical packaging market is valued at $4,357.7 million in 2025 and is projected to grow to $9,428.9 million by 2030.

        What is the growth rate for Mexico's pharmaceutical packaging market?

        Mexico's pharmaceutical packaging market is growing at a compound annual growth rate (CAGR) of 16.7% from 2025 to 2030.

        What factors are driving growth in Mexico's pharmaceutical packaging sector?

        Key drivers include increased domestic pharmaceutical production, rising healthcare demand, regulatory compliance requirements, cold-chain logistics expansion, and adoption of serialization and track-and-trace technologies in Mexico.

        Why is Mexico important for pharmaceutical packaging in North America?

        Mexico's proximity to the United States, established manufacturing infrastructure, and strategic location make it a critical hub for North American pharmaceutical supply chains and packaging solutions.

        What packaging innovations are emerging in Mexico's pharmaceutical market?

        Mexico's market is seeing growth in biologics packaging, sustainable materials, cold-chain solutions, and advanced serialization technologies to meet regulatory and supply chain requirements.

        RESEARCH METHODOLOGY

        The study involved four major activities to estimate the current size of the global pharmaceutical packaging market. Exhaustive secondary research was carried out to collect information on the market, the peer product market, and the parent product group market. The next step was to validate these findings, assumptions, and sizes with the industry experts across the value chain of pharmaceutical packaging through primary research. The top-down and bottom-up approaches were employed to estimate the overall size of the pharmaceutical packaging market. After that, market breakdown and data triangulation procedures were used to determine the size of different segments and sub-segments of the market.

        Secondary Research

        The market for the companies offering pharmaceutical packaging is arrived at by secondary data available through paid and unpaid sources, analyzing the product portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various secondary sources, such as Business Standard, Bloomberg, World Bank, and Factiva, were referred to in order to identify and collect information for this study on the pharmaceutical packaging market. In the secondary research process, various secondary sources were referred to identify and collect information related to the study. Secondary sources included annual reports, press releases, and investor presentations, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and technology-oriented perspectives.

        Primary Research

        In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side included industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), marketing directors, technology and innovation directors, and related key executives from several key companies and organizations operating in the pharmaceutical packaging market. After the complete market engineering (calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. Primary research was also conducted to identify the segmentation types, industry trends, competitive landscape of pharmaceutical packaging offered by various market players, and key market dynamics, such as drivers, restraints, opportunities, challenges, industry trends, and key player strategies. In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

        Pharmaceutical Packaging Market Size, and Share

        Notes: Other designations include sales, marketing, and product managers.
        Tier 1: Revenues greater than USD 1 Billion; Tier 2: Revenues between USD 500 million and USD 1
        Billion; and Tier 3: Revenues less than USD 500 million

        To know about the assumptions considered for the study, download the pdf brochure

        Market Size Estimation

        The top-down and bottom-up approaches were used to estimate and validate the size of the global pharmaceutical packaging market. These approaches were also used extensively to estimate the size of various dependent market segments. The research methodology used to estimate the market size included the following:

        Pharmaceutical Packaging Market : Top-Down and Bottom-Up Approach

        Pharmaceutical Packaging Market Top Down and Bottom Up Approach

        Data Triangulation

        After arriving at the overall market size using the market size estimation processes, the market was split into several segments and subsegments. The data triangulation procedure was employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment. The data was triangulated by studying various factors and trends from both the demand and supply sides.

        Market Definition

        Pharmaceutical packaging pertains to the materials and systems designed to protect, preserve, and deliver pharmaceutical products for oral, injectable, inhalation, and topical drug delivery modalities. It plays an important role in the stability and sterility of a drug, avoids contamination, and provides accurate dosing for the life of the product. Pharmaceutical packaging denotes the numerous varieties of available options, like plastic bottles, blister packs, vials, ampoules, prefillable syringes, tubes, pouches, and cartons to meet drug formulation requirements and regulatory obligations. Some of the significant functionalities of pharmaceutical packaging include moisture, oxygen, and light barrier protection, tamper evidence, patient convenience, and functionality with active pharmaceutical ingredients (APIs).

        Areas of interest include ISO 15378 relating specifically to primary packaging materials, ISO 9001 regarding quality management systems, and GMP compliance. The DSCSA and the EU FMD identified serialized, tracking, and anti-counterfeiting programs, creating an opportunity for the packaging industry to help with drug quality and patient safety.

        Stakeholders

        • Pharmaceutical packaging manufacturers
        • Raw material suppliers
        • Converters & processors
        • Distributors and traders
        • Industry associations and regulatory bodies
        • End users

        Report Objectives

        • To define, describe, and forecast the size of the pharmaceutical packaging market, based  on type, packaging type, drug delivery, raw material, and region in terms of value and volume
        • To provide detailed information on the significant drivers, restraints, opportunities, and challenges influencing the market
        • To strategically analyze micromarkets concerning individual growth trends, prospects, and their contribution to the market
        • To assess the growth opportunities in the market for stakeholders and provide details on the competitive landscape for market leaders
        • To forecast the market size of segments and subsegments for North America, Europe, Asia Pacific, South America, and the Middle East & Africa
        • To strategically profile key players and comprehensively analyze their market shares and core competencies
        • To analyze competitive developments such as acquisitions, product launches, expansions, partnerships, and agreements in the pharmaceutical packaging market
        • To provide the impact of AI/Gen AI on the market

        Available Customizations

        With the given market data, MarketsandMarkets offers customizations according to client-specific needs.

        The following customization options are available for the pharmaceutical packaging market report:

        Product Analysis

        • A product matrix that gives a detailed comparison of the product portfolio of each company

        Geographic Analysis as per Feasibility

        • A further breakdown of the pharmaceutical packaging market for additional countries

        Company Information

        • Detailed analysis and profiling of additional market players (up to five)

        Get the Full Pharmaceutical Packaging Market Report

        Full forecast, segment splits, and company analysis for all Pharmaceutical Packaging Market.

        Need a Tailored Report?

        Customize this report to your needs

        Get 10% FREE Customization

        Customize This Report
        Fact checked
        DMCA.com Protection Status